Sangamo Reports Positive Topline Results from STAAR Study
STAAR study demonstrated positive mean annualized estimated glomerular filtration rate (eGFR) slope at 52-weeks across all dosed patients in the study, which U.S. Food and...
Tag : Fabry Disease
AceLink Presents Phase 2 Results of AL01211 for Fabry Disease
AceLink Therapeutics, Inc., a clinical-stage biotech company developing next-generation oral substrate reduction therapies (SRTs), presented interim data from its ongoing Phase 2 clinical study of...